CMS has advised TowerBrook Capital Partners on the sale of AustroCel Hallein to Tokyo-based Oji Holdings Corporation.
The transaction remains contingent on regulatory approval.
AustroCel is an Austrian biorefinery that converts sustainably sourced wood residues into dissolving pulp, advanced bioethanol, and biodegradable, microplastic-free hydrogel granules under a zero-waste circular model.
TowerBrook is an international investment management firm co-headquartered in London and New York.
The CMS team included Austria-based Partners Clemens Grossmayer, Mariella Kapoun-Reiter, Thomas Hamerl, Robert Keisler, Stefan Paulmayer, Gabriela Staber, Marlene Wimmer-Nistelberger, Dieter Zandler, and Jens Winter, Senior Associate Christoph Birner, Associates Yara Al-Harbi, Ulrich Dallinger, Magdalena Gilhofer-Lenglinger, Daniel Grimmer, Lotta Gruber, Mathias Huber, Konstantin Kladivko, Caroline Pavitsits, Clara Puczynski, and Alexander Sommergruber, and Lawyers Anna Hiegelsperger, Clemens Macho, Andreas Lichtenberger, and Bernhard Oreschnik.
CMS did not respond to our inquiry on the matter.
